Drugs / Hib-CRM197
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02139228 | Nov → Dec 2014 | haemophilus infectious disease | Novartis Vaccines | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hib-CRM197 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02139228 ↗ |
| Modality | Vaccine | “Subjects treated with 3 doses of CRM 197 -conjugate Haemophilus influenzae type b vaccine (study vaccine)” NCT02139228 ↗ |